Delta Np63 Alpha Is A Common Inhibitory Target In Oncogenic Pi3k/Ras/Her2-Induced Cell Motility And Tumor Metastasis

Linshan Hu,Shan Liang,Hu Chen,Tao Lv,Junfeng Wu,Deshi Chen,Min Wu,Shengnan Sun,Haibo Zhang,Han You,Hongbin Ji,Yujun Zhang,Johann Bergholz,Zhi-Xiong Jim Xiao

DOI: https://doi.org/10.1073/pnas.1617816114

2017-01-01

Abstract:Activation of phosphatidylinositol 3 kinase (PI3K), Ras, and Her2 signaling plays a critical role in cancer development. Hotspot constitutive activating mutations in oncogenes, such as PIK3CA encoding the p110a catalytic subunit or RAS, as well as overexpression of Her2, are frequently found in human tumors and cancers. It has been well established that activation of these oncogenes profoundly promotes tumor metastasis, whereas decreased expression of Delta Np63a, the major protein isoform of the p53-related p63 expressed in epithelial cells, has been associated with cancer metastasis. In this study, we demonstrate that hotspot oncogenic mutations on PIK3CA and RAS, including p110 alpha(H1047R), K-Ras(G12V), and H-Ras(G12V), as well as activation of Her2, all led to suppression of Delta Np63a expression via Akt-fork-head transcription factor 3a (Akt-FOXO3a) signaling, resulting in increased cell motility and tumor metastasis. Expression of Delta Np63a effectively reversed p110 alpha(H1047R)-, K-Ras(G12V)-, H-Ras(G12V)-, or Her2-induced cell motility in vitro and tumor metastasis in mouse models. We show that Delta Np63a was a direct FOXO3a transcriptional target and that expression of FOXO3a and Delta Np63a was correlated in human cancer biopsy samples. Together, these results demonstrate that Delta Np63a is a common inhibitory target of oncogenic PI3K, Ras, and Her2, and that Delta Np63a may function as a critical integrator of oncogenic signaling in cancer metastasis.